Clinical Trials

NCT IdNCT04833582
TitleA Study of ZN-c3 in Combination With Gemcitabine in Subjects With Osteosarcoma
ConditionOsteosarcoma
StudyTypeInterventional
OrganizationK-Group Beta
Sponsor/CollaboratorsK-Group Beta
StatusNot yet recruiting
GenderAll
AgeGroupChild
Adult
Older Adult
Location (with distance)
  • Site 0106, Los Angeles, 90095 , United States
  • Site 0124, Oakland, 94609 , United States
  • Site 0104, Boston, 02215 , United States
  • Site 0105, New York, 10065 , United States
  • Site 0107, Cincinnati, 45229 , United States
  • Site 0123, Portland, 97239 , United States
  • Site 0109, Dallas, 75230 , United States
  • Site 0103, Houston, 77030 , United States
  • Site 0122, Seattle, 98195 , United States
DescriptionThis is a phase 1/2 study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.